drugset / Press release

Aelis Farma successfully completes the phase I trials with AEF0117

2018-07-01 · Aelis Farma · original aelisfarma.com ↗

These studies confirm the excellent safety profile of AEF0117 already observed in animals. AEF0117 has not currently identified toxic or adverse effect, with a therapeutic index > 14 000 in animals.

The release as fetched from its publisher. aelisfarma.com ↗